Acinetobacter baumannii represents a significant concern in nosocomial settings,
particularly in critically ill patients who are forced to remain in hospital for extended periods …

The increasing global incidence of multidrug-resistant (MDR) bacterial infections threatens
public health and compromises various aspects of modern medicine. Recognising the …

The spread of multidrug-resistant Acinetobacter baumannii in hospitals and nursing homes
poses serious healthcare challenges. Therefore, we aimed to isolate and characterize lytic …

Acinetobacter baumannii is an emerging opportunistic pathogen. It exhibits multi-, extreme-,
and pan-drug resistance against several classes of antibiotics. Capsular polysaccharide …

Antibiotics play an important role in the treatment of infectious diseases. Long-term overuse
or misuse of antibiotics, however, has triggered the global crisis of antibiotic resistance …

Acinetobacter baumannii is a challenging multidrug-resistant pathogen in healthcare. Phage
vB_AbaSi_W9 (GenBank: PP146379. 1), identified in our previous study, shows lytic activity …

Acinetobacter baumannii is a Gram-negative bacterium considered an emerging multi-drug-
resistant pathogen. Furthermore, this bacterium can survive in extreme environmental …

One of the significant issues in treating bacterial infections is the increasing prevalence of
extensively drug-resistant (XDR) strains of Acinetobacter baumannii. In the face of limited or …

ABSTRACT Introduction Acinetobacter baumannii complex (Abc) is currently a significant
cause of difficult-to-treat pneumonia. Due to the high prevalence rates of carbapenem-and …

Acinetobacter baumannii is an opportunistic pathogen that easily resists currently available
antibiotics. Phages are considered alternative therapeutic agents to conventional antibiotics …